| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Vortioxetine |
| Brand | Brintellix® |
| Indication | For the treatment of major depressive episodes in adults. |
| Assessment Process | |
| Rapid review commissioned | 01/10/2014 |
| Rapid review completed | 14/11/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| NCPE assessment outcome | Reimbursement Not Recommended |